{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-002667","form_type":"8-K","ticker":"ODYY","cik":"0001626644","company_name":"Odyssey Health, Inc.","filed_at":"2022-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.540529+00:00","generated_at":"2026-06-26T07:23:50.875023+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Odyssey extends convertible note maturity to March 2023, principal increased by $25K","bullets":["Extended maturity of $250K convertible note to March 1, 2023; added $25K to principal balance.","Holder Tysadco Partners LLC granted conversion moratorium until maturity unless default occurs.","Effective date March 31, 2022; filing reported April 11, 2022.","Odyssey Health Inc. (ODYY) entered amendment with Tysadco Partners LLC."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-002667","json":"https://secwatch.observer/filing/0001683168-22-002667.json","markdown":"https://secwatch.observer/filing/0001683168-22-002667.md","text":"https://secwatch.observer/filing/0001683168-22-002667.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626644/000168316822002667/0001683168-22-002667-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626644/000168316822002667/ody_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:23:50.875023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}